Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate
- PMID: 2072295
Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate
Abstract
Cationization of proteins in general enhances the cellular uptake of these macromolecules, and cationized antibodies are known to retain antigen binding properties. Therefore, cationized antibodies may be therapeutic and allow for "intracellular immunization." The present studies test the hypothesis that the tissue uptake of cationized immunoglobulin G (IgG) after intravenous administration may be greatly increased relative to the uptake of native proteins. The pharmacokinetics of cationized immunoglobulin G clearance from blood, and the volume of distribution of the cationized or native protein (albumin, IgG) for 10 organs was measured both in anesthetized rats and in an anesthetized adult Macaca irus cynomologous monkey. Initial studies on brain showed that serum factors inhibited uptake of 125I-cationized IgG, but not 3H-cationized IgG. The blood-brain barrier permeability surface area product for 3H-cationized IgG was 0.57 +/- 0.04 microliters min-1 g-1. The ratio of the volume of distribution of the 3-H-cationized IgG compared to 3H-labeled native albumin ranged from 0.9 (testis) to 15.7 (spleen) in the rat at 3 hr after injection, and a similarly enhanced organ uptake was observed in the primate. In conclusion, these studies demonstrate that cationization of immunoglobulin greatly increases organ uptake of the plasma protein compared to native immunoglobulins, and suggest that cationization of monoclonal antibodies may represent a potential new strategy for enhancing the intracellular delivery of these proteins.
Similar articles
-
Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein.Proc Natl Acad Sci U S A. 1989 Jun;86(12):4761-5. doi: 10.1073/pnas.86.12.4761. Proc Natl Acad Sci U S A. 1989. PMID: 2734318 Free PMC article.
-
Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector.J Pharmacol Exp Ther. 1990 Nov;255(2):893-9. J Pharmacol Exp Ther. 1990. PMID: 2243356
-
Enhanced cellular uptake and transport of polyclonal immunoglobulin G and fab after their cationization.J Drug Target. 2000;8(2):67-77. doi: 10.3109/10611860008996853. J Drug Target. 2000. PMID: 10852339
-
[Cationization, a process for the delivery of antibodies to the central nervous system. Problems encountered in its application for immunotherapy strategies such as those for clostridial poisoning].J Soc Biol. 2001;195(3):201-27. J Soc Biol. 2001. PMID: 11833458 Review. French.
-
Cationized Cellulose Materials: Enhancing Surface Adsorption Properties Towards Synthetic and Natural Dyes.Polymers (Basel). 2024 Dec 27;17(1):36. doi: 10.3390/polym17010036. Polymers (Basel). 2024. PMID: 39795439 Free PMC article. Review.
Cited by
-
Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier.J Cereb Blood Flow Metab. 2013 Dec;33(12):1983-92. doi: 10.1038/jcbfm.2013.160. Epub 2013 Sep 18. J Cereb Blood Flow Metab. 2013. PMID: 24045402 Free PMC article.
-
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly.Semin Cell Dev Biol. 2022 Jun;126:125-137. doi: 10.1016/j.semcdb.2021.12.002. Epub 2021 Dec 9. Semin Cell Dev Biol. 2022. PMID: 34896021 Free PMC article. Review.
-
Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy.EBioMedicine. 2019 Apr;42:157-173. doi: 10.1016/j.ebiom.2019.03.033. Epub 2019 Mar 22. EBioMedicine. 2019. PMID: 30910484 Free PMC article.
-
Passage of intravenous immunoglobulin and interaction with the CNS.J Neurol Neurosurg Psychiatry. 1994 Nov;57 Suppl(Suppl):21-5. doi: 10.1136/jnnp.57.suppl.21. J Neurol Neurosurg Psychiatry. 1994. PMID: 7964846 Free PMC article. Review. No abstract available.
-
Physiologically Based Pharmacokinetic Modeling to Characterize the Effect of Molecular Charge on Whole-Body Disposition of Monoclonal Antibodies.AAPS J. 2023 Apr 28;25(3):48. doi: 10.1208/s12248-023-00812-7. AAPS J. 2023. PMID: 37118220
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous